BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 10882074)

  • 1. The FBP interacting repressor targets TFIIH to inhibit activated transcription.
    Liu J; He L; Collins I; Ge H; Libutti D; Li J; Egly JM; Levens D
    Mol Cell; 2000 Feb; 5(2):331-41. PubMed ID: 10882074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The FUSE/FBP/FIR/TFIIH system is a molecular machine programming a pulse of c-myc expression.
    Liu J; Kouzine F; Nie Z; Chung HJ; Elisha-Feil Z; Weber A; Zhao K; Levens D
    EMBO J; 2006 May; 25(10):2119-30. PubMed ID: 16628215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dimerization of FIR upon FUSE DNA binding suggests a mechanism of c-myc inhibition.
    Crichlow GV; Zhou H; Hsiao HH; Frederick KB; Debrosse M; Yang Y; Folta-Stogniew EJ; Chung HJ; Fan C; De la Cruz EM; Levens D; Lolis E; Braddock D
    EMBO J; 2008 Jan; 27(1):277-89. PubMed ID: 18059478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defective interplay of activators and repressors with TFIH in xeroderma pigmentosum.
    Liu J; Akoulitchev S; Weber A; Ge H; Chuikov S; Libutti D; Wang XW; Conaway JW; Harris CC; Conaway RC; Reinberg D; Levens D
    Cell; 2001 Feb; 104(3):353-63. PubMed ID: 11239393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative characterization of the interactions among c-myc transcriptional regulators FUSE, FBP, and FIR.
    Hsiao HH; Nath A; Lin CY; Folta-Stogniew EJ; Rhoades E; Braddock DT
    Biochemistry; 2010 Jun; 49(22):4620-34. PubMed ID: 20420426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions between SAP155 and FUSE-binding protein-interacting repressor bridges c-Myc and P27Kip1 expression.
    Matsushita K; Tamura M; Tanaka N; Tomonaga T; Matsubara H; Shimada H; Levens D; He L; Liu J; Yoshida M; Nomura F
    Mol Cancer Res; 2013 Jul; 11(7):689-98. PubMed ID: 23594796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SAP155-mediated splicing of FUSE-binding protein-interacting repressor serves as a molecular switch for c-myc gene expression.
    Matsushita K; Kajiwara T; Tamura M; Satoh M; Tanaka N; Tomonaga T; Matsubara H; Shimada H; Yoshimoto R; Ito A; Kubo S; Natsume T; Levens D; Yoshida M; Nomura F
    Mol Cancer Res; 2012 Jun; 10(6):787-99. PubMed ID: 22496461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular basis of FIR-mediated c-myc transcriptional control.
    Cukier CD; Hollingworth D; Martin SR; Kelly G; Díaz-Moreno I; Ramos A
    Nat Struct Mol Biol; 2010 Sep; 17(9):1058-64. PubMed ID: 20711187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The XPB subunit of repair/transcription factor TFIIH directly interacts with SUG1, a subunit of the 26S proteasome and putative transcription factor.
    Weeda G; Rossignol M; Fraser RA; Winkler GS; Vermeulen W; van 't Veer LJ; Ma L; Hoeijmakers JH; Egly JM
    Nucleic Acids Res; 1997 Jun; 25(12):2274-83. PubMed ID: 9173976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alternative splicing of FBP-interacting repressor coordinates c-Myc, P27Kip1/cyclinE and Ku86/XRCC5 expression as a molecular sensor for bleomycin-induced DNA damage pathway.
    Rahmutulla B; Matsushita K; Satoh M; Seimiya M; Tsuchida S; Kubo S; Shimada H; Ohtsuka M; Miyazaki M; Nomura F
    Oncotarget; 2014 May; 5(9):2404-17. PubMed ID: 24811221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear targeting determinants of the far upstream element binding protein, a c-myc transcription factor.
    He L; Weber A; Levens D
    Nucleic Acids Res; 2000 Nov; 28(22):4558-65. PubMed ID: 11071946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hierarchical mechanisms build the DNA-binding specificity of FUSE binding protein.
    Benjamin LR; Chung HJ; Sanford S; Kouzine F; Liu J; Levens D
    Proc Natl Acad Sci U S A; 2008 Nov; 105(47):18296-301. PubMed ID: 19015535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hfp, the Drosophila homolog of the mammalian c-myc transcriptional-repressor and tumor suppressor FIR, inhibits dmyc transcription and cell growth.
    Cranna NJ; Mitchell NC; Hannan RD; Quinn LM
    Fly (Austin); 2011; 5(2):129-33. PubMed ID: 21245665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An essential role of alternative splicing of c-myc suppressor FUSE-binding protein-interacting repressor in carcinogenesis.
    Matsushita K; Tomonaga T; Shimada H; Shioya A; Higashi M; Matsubara H; Harigaya K; Nomura F; Libutti D; Levens D; Ochiai T
    Cancer Res; 2006 Feb; 66(3):1409-17. PubMed ID: 16452196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. c-myc suppressor FBP-interacting repressor for cancer diagnosis and therapy.
    Matsushita K; Tomonaga T; Kajiwara T; Shimada H; Itoga S; Hiwasa T; Kubo S; Ochiai T; Matsubara H; Nomura F
    Front Biosci (Landmark Ed); 2009 Jan; 14(9):3401-8. PubMed ID: 19273283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of far upstream element (FUSE) binding protein (FBP)-interacting repressor (FIR) supports growth of hepatocellular carcinoma.
    Malz M; Bovet M; Samarin J; Rabenhorst U; Sticht C; Bissinger M; Roessler S; Bermejo JL; Renner M; Calvisi DF; Singer S; Ganzinger M; Weber A; Gretz N; Zörnig M; Schirmacher P; Breuhahn K
    Hepatology; 2014 Oct; 60(4):1241-50. PubMed ID: 24824848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FBPs are calibrated molecular tools to adjust gene expression.
    Chung HJ; Liu J; Dundr M; Nie Z; Sanford S; Levens D
    Mol Cell Biol; 2006 Sep; 26(17):6584-97. PubMed ID: 16914741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SAP155-mediated c-myc suppressor far-upstream element-binding protein-interacting repressor splicing variants are activated in colon cancer tissues.
    Kajiwara T; Matsushita K; Itoga S; Tamura M; Tanaka N; Tomonaga T; Matsubara H; Shimada H; Habara Y; Matsuo M; Nomura F
    Cancer Sci; 2013 Feb; 104(2):149-56. PubMed ID: 23113893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-transmissible Sendai virus vector encoding c-myc suppressor FBP-interacting repressor for cancer therapy.
    Matsushita K; Shimada H; Ueda Y; Inoue M; Hasegawa M; Tomonaga T; Matsubara H; Nomura F
    World J Gastroenterol; 2014 Apr; 20(15):4316-28. PubMed ID: 24764668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TFIIH operates through an expanded proximal promoter to fine-tune c-myc expression.
    Weber A; Liu J; Collins I; Levens D
    Mol Cell Biol; 2005 Jan; 25(1):147-61. PubMed ID: 15601838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.